The stock of Natera Inc (NASDAQ: NTRA) has decreased by -3.38 when compared to last closing price of 90.33. Despite this, the company has experienced a -9.75% fall in its stock price over the last five trading sessions. Seeking Alpha reported 2024-03-22 that The global market size for personalized medicines is estimated to reach $1,233.23 billion by 2033, with North America experiencing significant growth in the oncology sector. Natera Inc., a diagnostic company, focuses on women’s health, oncology, and organ health, with major revenue drivers including non-invasive prenatal tests and personalized molecular residual disease tests. Natera reported a 43% year-on-year increase in revenue in Q4 2023, with a goal to achieve cash flow break even by Q3 2024 or sooner.
Is It Worth Investing in Natera Inc (NASDAQ: NTRA) Right Now?
Company’s 36-month beta value is 1.38.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NTRA is 113.03M, and currently, short sellers hold a 5.53% ratio of that floaft. The average trading volume of NTRA on April 19, 2024 was 1.44M shares.
NTRA’s Market Performance
The stock of Natera Inc (NTRA) has seen a -9.75% decrease in the past week, with a -4.36% drop in the past month, and a 29.19% gain in the past quarter. The volatility ratio for the week is 3.27%, and the volatility levels for the past 30 days are at 3.45% for NTRA. The simple moving average for the last 20 days is -6.08% for NTRA stock, with a simple moving average of 43.47% for the last 200 days.
Analysts’ Opinion of NTRA
Many brokerage firms have already submitted their reports for NTRA stocks, with Craig Hallum repeating the rating for NTRA by listing it as a “Buy.” The predicted price for NTRA in the upcoming period, according to Craig Hallum is $117 based on the research report published on April 08, 2024 of the current year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see NTRA reach a price target of $85, previously predicting the price at $68. The rating they have provided for NTRA stocks is “Outperform” according to the report published on February 20th, 2024.
BTIG Research gave a rating of “Buy” to NTRA, setting the target price at $85 in the report published on December 29th of the previous year.
NTRA Trading at 2.73% from the 50-Day Moving Average
After a stumble in the market that brought NTRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.68% of loss for the given period.
Volatility was left at 3.45%, however, over the last 30 days, the volatility rate increased by 3.27%, as shares sank -6.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +24.30% upper at present.
During the last 5 trading sessions, NTRA fell by -9.75%, which changed the moving average for the period of 200-days by +79.04% in comparison to the 20-day moving average, which settled at $92.65. In addition, Natera Inc saw 39.34% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NTRA starting from Moshkevich Solomon, who sale 80,000 shares at the price of $90.82 back on Apr 16 ’24. After this action, Moshkevich Solomon now owns 117,560 shares of Natera Inc, valued at $7,265,651 using the latest closing price.
Chapman Steven Leonard, the CEO AND PRESIDENT of Natera Inc, sale 6,816 shares at $93.13 during a trade that took place back on Apr 15 ’24, which means that Chapman Steven Leonard is holding 227,710 shares at $634,797 based on the most recent closing price.
Stock Fundamentals for NTRA
Current profitability levels for the company are sitting at:
- -0.41 for the present operating margin
- 0.46 for the gross margin
The net margin for Natera Inc stands at -0.4. The total capital return value is set at -0.39. Equity return is now at value -59.11, with -30.28 for asset returns.
Based on Natera Inc (NTRA), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at -0.66. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is -35.31.
Currently, EBITDA for the company is -404.95 million with net debt to EBITDA at 0.47. When we switch over and look at the enterprise to sales, we see a ratio of 9.42. The receivables turnover for the company is 3.89for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
In a nutshell, Natera Inc (NTRA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
